This mouse model exhibits robust phenotypes with early disease onset and short life span and recapitulates the altered expression of a number of genes observed in HD patients, including Drd2 and Ppp1r1b in the striatum early in the course of disease progression7, 12, 60, 61. The gene discussed is DRD2; the disease is Huntington disease.